BCL2 encodes for a mitochondrial membrane protein that regulates apoptosis and is expressed in B-cells. BCL6 encodes for a protein that acts as a transcriptional repressor involved in the regulation of lymphoid development and function.
Abacus dx is pleased to announce the launch of the latest assay from the Asuragen spinal muscular atrophy (SMA) portfolio – AmplideX® PCR/CE SMN1/2 Plus Kit*.
Idylla™, Biocartis’ fully automated, real-time PCR based molecular diagnostics system, is designed to offer fast and easy access to clinical molecular diagnostic information, anywhere and anytime.
Abacus dx is pleased to announce the launch of the Invivoscribe MRD T-Cell Bundled Solution* which includes LymphoTrack T-Cell Low Positive Controls, LymphoQuant T-Cell Internal Controls and NGS-powered LymphoTrack Dx Assays.
This webinar will explore how insights gained through NGS translate to the development of improved treatment of lymphoid malignancies.
Breast cancer is the most common cancer affecting women in Australia and New Zealand1 and the second most commonly diagnosed cancer in Australia2.
Abacus dx is pleased to announce the newest addition to Streck’s trusted blood collection tube portfolio, RNA Complete BCT™.
Biocartis is pleased to announce the launch of the Idylla™ ctEGFR Mutation Assay (RUO1). This assay is the liquid biopsy version of the solid biopsy Idylla™ EGFR Mutation Test (CE-IVD).
Abacus dx is pleased to announce the release of the latest probe from ZytoVision, ZytoLight® SPEC GATA2/MECOM Dual Color Fusion Probe.